Acceliant Showcases its eClinical Suite at BioPharma Asia Convention 2013

BANGALORE, India - March 22, 2013 - PRLog -- At the event, Ven Thangaraj (http://www.acceliant.com/about-us/ven-thangaraj.php), CTO of Acceliant, and his team demonstrated the comprehensive features of the eClinical Suite and discussed the advantages of a single e-PRO (http://www.acceliant.com/products/electronic-patient-reported-outcomes.php)/EDC (http://www.acceliant.com/products/comprehensive-edc.php) system over modular and disparate systems.
We would like to thank all the attendees whose presence made the event a huge success for us. We immensely value the interest shown in our product and appreciate the insights provided.

Speaking on the success at the convention, Santhosh Nagaraj (http://www.acceliant.com/about-us/santhosh-nagaraj.php), Sales Head, said, "The convention was a great platform to expand our reach and make new connections with the global pharmaceutical and CRO firms. We foresee several partnership opportunities, especially due to the growing demand for efficient and cost-effective clinical data management solutions."

"Our eClinical Suite (http://www.acceliant.com/about-us/acceliant-clinical-tria...) boasts of integrated EDC/ePRO, UTB and trial management modules. Its advanced, user-friendly features like patient engagement, mobility, and multilingual support drive speed and efficiency across all phases of clinical trials. Customer interactions and insights gathered from experts at the convention will help boost our efforts to serve the life sciences industry better," emphasized Prashant Bhavaraju (http://www.acceliant.com/about-us/prashant-bhavaraju.php), Chief Marketing Officer.
Acceliant eClinical Suite

Acceliant eClinical Suite (http://www.acceliant.com/) is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.